Rezultati pretrage - Hugo Cheinquer
- Prikaz rezultata 1 – 20 od 57
- Idi na sljedeću stranicu
-
1
Treatment of chronic hepatitis C virus infection in the near future od Hugo Cheinquer
Izdano 2013Editorial -
2
-
3
-
4
-
5
-
6
-
7
Cost-effectiveness analysis of treatment with peginterferon-alfa-2a versus peginterferon-alfa-2b for patients with chronic hepatitis C under the public payer perspective in Brazil od Fabio MR Barros, Hugo Cheinquer, C.T. Tsuchiya, E.A.V. Santos
Izdano 2013Artigo -
8
-
9
Effect of HFE gene polymorphism on sustained virological response in patients with chronic hepatitis C and elevated serum ferritin od Silvia Coelho-Borges, Hugo Cheinquer, Fernando Herz Wolff, Nelson Cheinquer, Luciano Krug, Patrícia Ashton‐Prolla
Izdano 2012Artigo -
10
DOES INSULIN RESISTANCE IMPAIR THE VIROLOGICAL RESPONSE TO PEGINTERFERON/RIBAVIRIN IN CHRONIC HEPATITIS C GENOTYPE 3 PATIENTS? od Marcela Laurito, Giovanni Faria Silva, Hugo Cheinquer, Rajani Sharma, Elizabeth C. Verna, Edison Roberto Parise
Izdano 2018Artigo -
11
-
12
-
13
P-33 IMPACT OF SUSTAINED VIROLOGIC RESPONSE ON GLUCOSE PARAMETERS AMONG CHRONIC HEPATITIS C PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS od Hugo Cheinquer, Fábia Benetti, Alexandre de Araújo, Italo de Maman, Cristina Cheinquer Coelho Borges, Fernando Wolff Herz
Izdano 2023Artigo -
14
Impact of sustained virologic response on glucose parameters among patients with chronic hepatitis C treated with direct-acting antivirals od Fábia Benetti, Alexandre de Araújo, Italo de Maman, Cristina Coelho Borges Cheinquer, Fernando Herz Wolff, Hugo Cheinquer
Izdano 2024Artigo -
15
-
16
A Randomized Study of Peginterferon Lambda-1a Compared to Peginterferon Alfa-2a in Combination with Ribavirin and Telaprevir in Patients with Genotype-1 Chronic Hepatitis C od Robert Flisiak, Mitchell L. Shiffman, Juan Arenas, Hugo Cheinquer, И. Г. Никитин, Yuping Dong, Khurram Rana, Subasree Srinivasan
Izdano 2016Artigo -
17
-
18
-
19
-
20
Alati za pretragu:
Povezani predmeti
Medicine
Internal medicine
Virus
Gastroenterology
Hepatitis C
Hepatitis C virus
Immunology
Virology
Cirrhosis
Ribavirin
Hepatocellular carcinoma
Environmental health
Adverse effect
Viral load
Chronic hepatitis
Liver disease
Population
Biology
Disease
Hepatitis B
Hepatitis B virus
Intensive care medicine
Randomized controlled trial
Antiretroviral therapy
Gene
Confidence interval
Dasabuvir
Discontinuation
Genotype
HBsAg